Stockholders' Equity

6 Months Ended

Jun. 30, 2014

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Stock-based compensation: The Company included the following amounts for stock-based compensation expense, which related to stock options, RSUs, and the Company’s employee stock purchase plan (“ESPP”), in the consolidated statements of comprehensive income (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2014		2013		2014		2013
Cost of revenues	$	113	$	228	$	272	$	447
Engineering and technology	315		319		744		572
Sales and marketing	722		526		1,641		1,003
General and administrative	1,808		1,680		3,709		3,216
Total	$	2,958	$	2,753	$	6,366	$	5,238
Excluded and capitalized as part of internal-use software	$	23	$	23	$	54	$	34

In May 2012, the Company granted 190,000 stock options to certain employees who perform acquisition-related activities. The awards' vestings were predicated on completing "qualified acquisitions" under the terms of the awards. The completion of the HSW acquisition on May 30, 2014 constituted a qualified acquisition under the terms of the awards. The vestings of the awards resulted in a charge of $0.3 million to stock-based compensation expense in the three and six months ended June 30, 2014, which was classified in "General and administrative" expense.

Total net shares issued for stock options exercised, RSUs vested, and shares purchased pursuant to the ESPP were as follows (in thousands):

	Three months ended June 30,		Six months ended June 30,
	2014	2013	2014	2013
RSUs vested	129	128	205	224
Stock options exercised	132	82	140	118
Shares purchased pursuant to ESPP	—	—	36	36
Total	261	210	381	378

Warrant: On August 23, 2011, the Company issued a warrant (the “Warrant”) to purchase 1.0 million shares of Blucora common stock, exercisable at a price of $9.62 per share. The Warrant originally was considered stock-based compensation and was scheduled to expire on August 23, 2014, but the completion of the TaxACT acquisition on January 31, 2012 was an event under the Warrant’s terms that extended the expiration date to the earlier of August 23, 2017 or the effective date of a change of control of Blucora. Subsequent to the extension, the Company treated the award as a derivative instrument (see “Note 2: Summary of Significant Accounting Policies”), and the Warrant’s fair value was determined each reporting period with gains or losses related to the change in fair value recorded in “Other loss, net.” On November 21, 2013, the Warrant was exercised and 1.0 million shares of Blucora common stock were purchased for an aggregate exercise price of $9.6 million.

Stock repurchase program: In February 2013, the Company’s Board of Directors approved a stock repurchase program whereby the Company may purchase its common stock in open-market transactions. In May 2014, the Board of Directors increased the repurchase authorization, such that the Company may repurchase up to $85.0 million of its common stock, and extended the repurchase period through May 2016. Repurchased shares will be retired and resume the status of authorized but unissued shares of common stock. During the six months ended June 30, 2014, the Company purchased 1.4 million shares in open-market transactions at a total cost, exclusive of purchase and administrative costs, of $25.7 million and an average price of $18.05 per share. As of June 30, 2014, the Company may repurchase an additional $49.3 million, which also takes into consideration share repurchases during 2013 of $10.0 million, of its common stock under the repurchase program.